<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392806</url>
  </required_header>
  <id_info>
    <org_study_id>SLU Protocol # 24949</org_study_id>
    <nct_id>NCT02392806</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Study of Bubble CPAP Devices in the NICU</brief_title>
  <official_title>Comparative Effectiveness Study of Bubble CPAP Devices in the NICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marya Strand, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Louis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple different devices are available to provide Bubble CPAP to preterm and newborn
      infants. The most significant difference between these devices is the size of the bubble
      produced by the exhalation limb. This study will determine if one Bubble CPAP device
      (BabiPlus vs B&amp;B) is more effective in improving oxygenation and decreasing extubation
      failure in the extremely low birthweight population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome: Bubble CPAP failure (re-intubation or use of non-invasive positive pressure
      ventilation) within 72 hours following extubation Secondary outcome: Number of infants that
      reach 21% inspired oxygen during initial study period Secondary outcome: Apnea/bradycardia
      events in the initial study period Secondary outcome: Mean oxygen requirement following
      initial study period

      Population: Infants born at &lt;=1250 grams birth weight but &gt;= 500 grams birth weight

      Randomization: Equal allocation stratified by gestational age (&lt;27 weeks, &gt;=27 weeks)

      Study diagram:

      72h 24h X----------&gt;X1-----------&gt;Y2 Y----------&gt;Y1-----------&gt;X2 Infants will be randomly
      assigned to treatment X (BabiPlus, control group) or treatment Y (B&amp;B Bubbler, intervention
      group). The primary outcome is bubble CPAP failure during the first 72 hours following
      extubation, measured at time point 1 in the diagram. Bubble CPAP failure is defined as
      requiring re-intubation or non-invasive positive pressure ventilation (NIPPV), requiring FiO2
      of &gt;60% for one hour or a pCO2 measurement of &gt;65 mm Hg. For those infants that remain on
      CPAP during the initial study period, the number that reach 21% inspired oxygen for &gt;12
      consecutive hours will be compared between groups. This difference will also be analyzed
      using a Chi square test.

      Those infants that remain on CPAP following the 72 hour initial study period (e.g., did not
      meet primary outcome criteria) will be crossed over to the opposite treatment arm for at
      least 24 hours. The minimum oxygen requirement required to keep the saturations in the
      ordered range, per standard NICU guidelines, will be recorded and compared between time
      points 1 and 2.

      This study design is complex due to the nature of the disease of these patients. Each day
      every infant's premature pulmonary disease is evolving. There is no way to control for this.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Extubation Failure</measure>
    <time_frame>Within 72 hours of extubation</time_frame>
    <description>Bubble CPAP failure (re-intubation or use of non-invasive positive pressure ventilation) within 72 hours following extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygenation - Oxygen Saturation Via Pulse Oximetry Recorded Hourly</measure>
    <time_frame>96 hours</time_frame>
    <description>Number of infants that reach 21% inspired oxygen during initial study period of 72 hours plus the crossover period of 24 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>BabiPlus, Respiralogics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device for 24 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B&amp;B Bubbler, B&amp;B medical Technologies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device for 24 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bubble CPAP- BabiPlus, Respiralogics</intervention_name>
    <description>Infant will be randomized to BabiPlus Bubbler at time of extubation</description>
    <arm_group_label>BabiPlus, Respiralogics</arm_group_label>
    <other_name>Bubble Continuous Positive Airway Pressure (BCPAP)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices</intervention_name>
    <description>Infant will be randomized to B&amp;B Bubbler at time of extubation</description>
    <arm_group_label>B&amp;B Bubbler, B&amp;B medical Technologies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infant delivered at &gt;=500 grams and &lt;=1250 grams birth weight.

          2. Infant requires intubation for mechanical ventilation within the first 48 hours
             following delivery.

          3. Infant has received exogenous surfactant during mechanical ventilation.

        Exclusion Criteria:

          1. Decision by attending physician to redirect to comfort care

          2. Congenital condition that precludes the use of CPAP (choanal atresia, diaphragmatic
             hernia, etc.)

          3. Birth weight &gt;1250 grams or &lt;500 grams.

          4. Non-English speaking parents. -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noah H Hillman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Director, Pediatrics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <results_first_submitted>September 14, 2017</results_first_submitted>
  <results_first_submitted_qc>November 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 26, 2017</results_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>St. Louis University</investigator_affiliation>
    <investigator_full_name>Marya Strand, MD</investigator_full_name>
    <investigator_title>Associate Professor, Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Continuous positive airway pressure</keyword>
  <keyword>CPAP</keyword>
  <keyword>Bubble CPAP</keyword>
  <keyword>Extubation failure</keyword>
  <keyword>Preterm infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bubble CPAP- BabiPlus, Respiralogics</title>
          <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device
Bubble CPAP- BabiPlus, Respiralogics: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
        <group group_id="P2">
          <title>Bubble CPAP - B&amp;B Bubbler, B&amp;B Medical Technologies</title>
          <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device
Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bubble CPAP- BabiPlus, Respiralogics</title>
          <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device
Bubble CPAP- BabiPlus, Respiralogics: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
        <group group_id="B2">
          <title>Bubble CPAP - B&amp;B Bubbler, B&amp;B Medical Technologies</title>
          <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device
Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="21"/>
            <count group_id="B3" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Weeks Gestational Age</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.0" spread="2.0"/>
                    <measurement group_id="B2" value="25.4" spread="1.4"/>
                    <measurement group_id="B3" value="25.7" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Extubation Failure</title>
        <description>Bubble CPAP failure (re-intubation or use of non-invasive positive pressure ventilation) within 72 hours following extubation</description>
        <time_frame>Within 72 hours of extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bubble CPAP- BabiPlus, Respiralogics</title>
            <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device
Bubble CPAP- BabiPlus, Respiralogics: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
          </group>
          <group group_id="O2">
            <title>Bubble CPAP - B&amp;B Bubbler, B&amp;B Medical Technologies</title>
            <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device
Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Extubation Failure</title>
          <description>Bubble CPAP failure (re-intubation or use of non-invasive positive pressure ventilation) within 72 hours following extubation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygenation - Oxygen Saturation Via Pulse Oximetry Recorded Hourly</title>
        <description>Number of infants that reach 21% inspired oxygen during initial study period of 72 hours plus the crossover period of 24 hours</description>
        <time_frame>96 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bubble CPAP- BabiPlus, Respiralogics</title>
            <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device
Bubble CPAP- BabiPlus, Respiralogics: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
          </group>
          <group group_id="O2">
            <title>Bubble CPAP - B&amp;B Bubbler, B&amp;B Medical Technologies</title>
            <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device
Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygenation - Oxygen Saturation Via Pulse Oximetry Recorded Hourly</title>
          <description>Number of infants that reach 21% inspired oxygen during initial study period of 72 hours plus the crossover period of 24 hours</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bubble CPAP- BabiPlus, Respiralogics</title>
          <description>Infants randomized to the BabiPlus device will be extubated to BabiPlus Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the B&amp;B Bubbler device
Bubble CPAP- BabiPlus, Respiralogics: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
        <group group_id="E2">
          <title>Bubble CPAP - B&amp;B Bubbler, B&amp;B Medical Technologies</title>
          <description>Infants randomized to the B&amp;B Bubbler device will be extubated to B&amp;B Bubbler Bubble CPAP device and after 72 hours, if the infant has remained extubated, will be crossed-over to the BabiPlus device
Bubble CPAP- B&amp;B Bubbler, B&amp;B Medical devices: Infant will be randomized to BabiPlus verses B&amp;B Bubbler at time of extubation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Noah Hillman</name_or_title>
      <organization>Saint Louis University</organization>
      <phone>3145779292</phone>
      <email>noah.hillman@health.slu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

